5 results match your criteria: "Reproductive Medicine Unit-GynePro Medical Centers[Affiliation]"
J Assist Reprod Genet
June 2020
Reproductive Medicine Unit- GynePro Medical Centers, GynePro Medical, Via T. Cremona, 8 -, 40137, Bologna, Italy.
Purpose: To investigate the clinical efficacy of a "Universal Warming" protocol, based on subsequent steps with 1 M and 0.5 M concentration of extracellular cryoprotectant (ECCP), on shipped oocytes. Oocytes are vitrified using different brands of ready-to-use kits which recommend that the use of their own warming kit and combining different vitrification/warming kits may have legal consequences for assisted reproductive (AR) centers, until this practice has been validated with clinical studies.
View Article and Find Full Text PDFJ Assist Reprod Genet
October 2018
Reproductive Medicine Unit- GynePro Medical Centers GynePro Medical, Via T. Cremona, 8-40137, Bologna, Italy.
Purpose: To study the efficacy and efficiency of a "universal warming protocol" for vitrified human embryos, based on subsequent steps with 1 and 0.5 M concentration of extracellular cryoprotectant (ECCP).
Method: Two studies on patients undergoing fertility treatments via ICSI: a prospective randomized controlled trial (RCT) and a retrospective cohort study (CS).
J Assist Reprod Genet
January 2010
Reproductive Medicine Unit-GynePro Medical Centers, GynePro Medical, Via T. Cremona, 8-40137, Bologna, Italy.
Purpose: Hyaluronic Acid (HA) has a role as "physiologic selector" for spermatozoa prior to intracytoplasmic sperm injection (ICSI). The objective of this study is to analyze the results achievable by the introduction of a routine HA-ICSI programme.
Methods: We retrospectively observed 293 couples treated with HA-ICSI versus 86 couples treated with conventional PVP-ICSI (historical control group).
Reprod Biomed Online
June 2009
Reproductive Medicine Unit-GynePro Medical Centers, Bologna, Italy.
The potential, limits and safety of oocyte freezing are still being explored. Female age may play a relevant role in treatment outcome. The present study is the first report of the birth and normal development of a baby conceived from frozen oocytes of a 40-year-old woman.
View Article and Find Full Text PDF